# Final client delivery report

**Assessment date:** 8 November 2026  
**Application:** AGHARAS VISION OPTIQUE, local Next.js storefront and owner dashboard.

## Verdict

**UPDATED LOCAL DEMO READY. FUNCTIONAL DELIVERY READY: NOT GRANTED.** The optimized production demo was rebuilt from the latest verified source and browser-checked against a fresh isolated synthetic schema. Storefront and owner dashboard responsive checks pass at 390/768/1024/1440 px. Corrective-lens commerce remains blocked on qualified optician decisions, and owner/legal/commercial content needs approval. This verdict supports a local demonstration with clearly identified synthetic data only—not real-order operation or public launch.

No reproducible application-code defect was confirmed in the final clean runs. No public launch, hosting, real payments, or real email is authorized or implied.

## Current check results

| Check | Current result |
|---|---|
| Prisma schema validation | PASS (`npx prisma validate`) |
| TypeScript / Next route type generation | PASS (`npm run typecheck`) |
| Vitest | PASS — 122/122 tests, 18 files; isolated synthetic test databases |
| Optimized production build | PASS (`node_modules/.bin/next build`, isolated `NEXT_DIST_DIR`, existing generated Prisma client); final demo build includes responsive dashboard min-width fix |
| `npm run build` wrapper | First attempt failed at `prisma generate` with Windows `EPERM` while dev server held Prisma DLL; Next build then passed directly. No source/build defect found. |
| Playwright Chromium | PASS — Playwright 1.64.1, Chromium 156.0.8078.4 (revision 1248), dedicated D: cache |
| Full Playwright E2E | PASS — 36/36, 0 failed/skipped; clean schema B, production server |
| Full functional acceptance | PASS — 44/44, 0 failed/skipped/timeouts; clean isolated schema; includes compatibility, optical form, atypical values, forged Progressive and stale-cart regressions |
| Updated demo browser walkthrough | PASS — homepage, catalogue, product and configurator HTTP 200; owner login/dashboard, CMS banners, appearance and settings HTTP 200; six promotional assets HTTP 200/WebP; zero console/page errors or failed requests |
| Responsive updated demo | PASS — storefront and owner dashboard at 390/768/1024/1440px, no horizontal overflow; CMS/appearance/settings checked at 1440px; screenshots and JSON evidence in `artifacts/client-demo-refresh/` |
| Security/privacy | PASS in synthetic tests — owner-only prescription retrieval (200/no-store), anonymous denial (401), public media denial (404); RBAC/security E2E and acceptance passed |
| Dependency audits | PASS — `npm audit` and `npm audit --omit=dev`: 0 vulnerabilities |
| `git diff --check` | PASS; line-ending warnings only |
| Real SMTP / payment / hosted services | NOT RUN — intentionally out of scope |

## Critical functions and remaining limits

Current browser verification exercised guest COD order creation, price tampering rejection, idempotency, stock transactions, product publication/media, owner CRUD/CMS/order/settings, RBAC, exact optical compatibility enforcement, prescription storage privacy, and email outbox with discard transport. A separate clean local demo schema contains seeded synthetic catalog data but **zero compatibility rules**; unreviewed corrective-lens options therefore remain blocked.

Outstanding blockers:

1. Qualified optician: approve/reject each real frame + variant + lens + index + full treatment combination with documented evidence; until then keep corrected-lens orders disabled for unreviewed combinations.
2. Owner/legal reviewer: confirm real business identity/contact data, legal terms, warranty/delivery claims, and newsletter incentive/consent/unsubscribe behavior.
3. Owner/data protection contact: decide prescription retention and deletion period.
4. Before any public operation, separately scope hosting, durable private storage, backups, monitoring, and authorized SMTP; these are not included in this local handover.

## Security and operational boundaries

- No data in `agharas/public` was modified by this session.
- New demo schema `agharas_test.agharas_demo_refresh_20261108_01` was confirmed absent before creation, verified before/after migration and seed, and contains six current migrations, 12 synthetic products, one seed order, Progressive inactive, and zero compatibility rules. Other synthetic test schemas remain separate.
- Synthetic acceptance approvals were explicitly labeled test-only; the clean demo schema has zero optical rules.
- No credentials or secrets are included in these reports.
- No real email was sent; no online payment was enabled.
- Port 3000 was left untouched. Existing development app at port 3002 remains running; the updated optimized local demo is at `http://127.0.0.1:3106/`, using `.next-client-demo-refresh-final-20261108`, `EMAIL_TRANSPORT=discard`, and isolated local media paths.
- Hosted storage, SMTP, backups, monitoring, and deployment remain outside this local run.
- Extensive pre-existing tracked modifications and untracked files were preserved.

## Files created or updated in this assessment

- `docs/FINAL_DELIVERY_DEFECT_REGISTER.md`
- `docs/FINAL_CLIENT_DELIVERY_REPORT.md`
- `docs/CLIENT_HANDOVER_GUIDE_FR.md`
- `docs/IMPLEMENTATION_PROGRESS.md` (assessment note appended)
- `playwright.config.ts` (opt-in reuse for an already isolated production test server; default behavior preserved)
- `.gitignore` (ignore only this session's local emergency build and Chromium cache artifacts)

The demo’s public purchase options omit Progressive and the prescription-entry UI omits Addition/ADD and EP. Technical validation and server-side rejection of forged Progressive, PENDING and INCOMPATIBLE combinations remain enforced; atypical but technically valid measurements are not blocked by clinical plausibility heuristics. Browser walkthroughs were read-only except establishing the synthetic owner session. No orders, stock, settings, CMS content, or optical decisions were changed during browser verification. Synthetic test approvals are not professional decisions. Use owner credentials already held locally in environment configuration; they are intentionally not reproduced in this report.
